Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: ALXN1840 Wilson Phase III met primary endpoint
Investegate announcements from AstraZeneca PLC, ALXN1840 Wilson Phase III met primary endpoint
Source: investegate.co.uk
📰 Focus Phase News
Focus Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Focus Phase. Real-time updates on events, politics, business and more.
ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement
Positive high-level results from the FoCus Phase III trial in Wilson disease showed ALXN1840 met the primary endpoint with a statistically significant...
Source: miragenews.com